• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Ipsen joins ADC race via $900M biobuck deal with Sutro, chasing same target as Merck,...

cafead

Administrator
Staff member
  • cafead   Apr 02, 2024 at 11:42: AM
via Ipsen has become the newest entrant in the antibody-drug conjugate (ADC) race, handing over around $90 million in near-term payments to Sutro Biopharma in return for the global rights to a preclinical candidate.

article source
 

<